Clinical Trials

33 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05393297 2023-09-13

InGReS

15 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT06023875 2023-09-05

NCCCNRHNSCC

30 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05451576 2023-08-31

Sodium Selenite Supplementation in Patients With Head and Neck Cancer

60 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT06016400 2023-08-29

Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma

Phase 2/3 Unknown

412 enrolled

Squamous Cell Carcinoma of Head and Neck, Stomatitis

NCT04297995 2023-08-08

Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors

131 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05783921 2023-07-28

A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell Carcinoma

60 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT05965154 2023-07-28

Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma

22 enrolled

Phase EARLY_PHASE1 Unknown

Squamous Cell Carcinoma of Head and Neck

NCT05831930 2023-04-26

The Effect of Nitozumab in the Treatment of Head and Neck Squamous Cell Carcinoma

62 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05803915 2023-04-07

Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical Therapy

57 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05791149 2023-03-30

EPSACO

60 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT01590355 2023-03-08

ORATOR

68 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05749042 2023-03-01

A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma

70 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05721443 2023-02-10

Cetuximab Plus Dalpicilib in Patients With HPV Negative, PD-1 Resistant R/M HNSCC

26 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03775525 2022-12-23

GEN602

BreastDermatologicGastrointestinalHead & NeckLymphoidSarcoma

127 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Basal Cell, Colonic Neoplasms, Lymphoma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Lymphoma, T-Cell, Cutaneous

NCT05611463 2022-11-10

CHANCE

25 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05602792 2022-11-02

A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors

BreastGastrointestinalHead & NeckSarcoma

233 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Esophageal Neoplasms, Sarcoma

NCT03817307 2022-10-26

USPIO-NECK

25 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04803331 2022-10-26

MAG-NODE

10 enrolled

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

NCT05024383 2022-09-28

Dissecting the Heterogeneity of Oral Cancer Pain

80 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05505877 2022-08-18

Phase I/IIa Study of BR790 in Combination With Tislelizumab in Adult Subjects With Advanced Solid Tumors

160 enrolled

Head & NeckThoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung

NCT05351762 2022-07-05

Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC

55 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02748707 2022-04-28

ERLO-XIB

64 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT04213404 2022-04-21

RISE-HN

13 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03799744 2022-03-28

Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma

20 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT05299203 2022-03-28

BH4 in the Prevention and Treatment of Radiation-induced Skin Reactions for Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)

18 enrolled

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Radiodermatitis

NCT05294900 2022-03-25

NEOS

79 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05075122 2022-03-09

FOCUS

75 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05267353 2022-03-04

Develop and Test the 'Multi-Faced Continuous Exercise Program' in Operable Head and Neck Cancer Patients

390 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT05202275 2022-01-21

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

43 enrolled

Squamous Cell Carcinoma of Head and Neck, Nausea, Radiation Injuries, Vomiting

NCT02915432 2021-12-13

The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC

GastrointestinalHead & Neck

401 enrolled 1 FDA

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Esophageal Squamous Cell Carcinoma

NCT05136768 2021-11-29

LM-HNSCC

50 enrolled

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis

NCT05117138 2021-11-11

Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors

DermatologicHead & NeckThoracic

39 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma

NCT04367909 2021-11-08

A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma

68 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03291002 2021-11-04

Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC

98 enrolled

DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Adenoid Cystic, Melanoma

NCT04650633 2021-10-29

SHR-1701 in Patients With Recurrent/Metastatic Scchn

130 enrolled